BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24093201)

  • 1. Paraneoplastic optic neuropathy and retinopathy associated with colon adenocarcinoma.
    Chao D; Chen WC; Thirkill CE; Lee AG
    Can J Ophthalmol; 2013 Oct; 48(5):e116-20. PubMed ID: 24093201
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.
    Carboni G; Forma G; Bond AD; Adamus G; Iannaccone A
    Doc Ophthalmol; 2012 Aug; 125(1):63-70. PubMed ID: 22569848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic neuroendocrine paraneoplastic optic neuropathy: confirmation with antibody to optic nerve and hepatic metastasis.
    Slamovits TL; Posner JB; Reidy DL; Thirkill CE; Keltner JL
    J Neuroophthalmol; 2013 Mar; 33(1):21-5. PubMed ID: 22926698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic optic neuropathy from cutaneous melanoma detected by positron emission tomographic and computed tomographic scanning.
    Schoenberger SD; Kim SJ; Lavin P
    Arch Ophthalmol; 2012 Sep; 130(9):1223-5. PubMed ID: 22965609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined use of pattern electroretinography and pattern visual evoked potentials in neuroophthalmological practice].
    Benedek K; Pálffy A; Bencsik K; Fejes I; Rajda C; Tuboly G; Liszli P
    Ideggyogy Sz; 2008 Jan; 61(1-2):33-41. PubMed ID: 18372773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of electrophysiology in determining the diagnosis of visual dysfunction in neuro-ophthalmology patients.
    Yap GH; Chen LY; Png R; Loo JL; Tow S; Mathur R; Chia A
    Doc Ophthalmol; 2015 Dec; 131(3):189-96. PubMed ID: 26471028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
    Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
    Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
    [No Abstract]   [Full Text] [Related]  

  • 8. Multifocal visual evoked potential, multifocal electroretinography, and optical coherence tomography in the diagnosis of subclinical loss of vision.
    Hedges TR; Quireza ML
    Ophthalmol Clin North Am; 2004 Mar; 17(1):89-105. PubMed ID: 15102515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.
    Rahimy E; Sarraf D
    Surv Ophthalmol; 2013; 58(5):430-58. PubMed ID: 23969019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 11. Linezolid-induced photoreceptor dysfunction masquerading as autoimmune retinopathy.
    Grohmann SM; Berman A; Grassi MA
    Doc Ophthalmol; 2020 Feb; 140(1):77-82. PubMed ID: 31587118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-modality therapy for metastatic colorectal cancer-ready for prime time?
    Chua TC; Marshall JL; Marshall MB; Esquivel J
    Am Surg; 2010 Jul; 76(7):777-8. PubMed ID: 20698392
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis difficulties in a patient with progressive loss of vision - a case report.
    Cristescu TR
    Rom J Ophthalmol; 2017; 61(1):60-64. PubMed ID: 29450373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowly progressive cancer-associated retinopathy.
    Saito W; Kase S; Ohguro H; Furudate N; Ohno S
    Arch Ophthalmol; 2007 Oct; 125(10):1431-3. PubMed ID: 17923561
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics of paraneoplastic retinopathy and optic neuropathy].
    Huang HB; Wei SH; Li Y; Wang FX; Yao Y; Jiang CH; Yin ZQ; Zhang MN; Wei WB
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):507-13. PubMed ID: 24119963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 18. The wide gulf between stage III and stage IV colon cancer.
    Ting DT; Ryan DP
    Lancet Oncol; 2014 Jul; 15(8):785-6. PubMed ID: 24928084
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of reduced electroretinographic responses in thymoma-associated retinopathy: a case report and literature review.
    Mizobuchi K; Hayashi T; Katagiri S; Kim E; Ishiba Y; Watanabe S; Furukawa T; Nakano T
    Doc Ophthalmol; 2020 Oct; 141(2):195-204. PubMed ID: 32239315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comprehensive electrophysiological study of the system of vision in children and adolescents with congenital myopia and diseases of the retina and optic nerve].
    Zislina NN; Shamshinova AM; Kozhevnikova OM; Loran SI
    Vestn Oftalmol; 1996; 112(1):20-3. PubMed ID: 8659063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.